Human papillomavirus infection and survival in oral squamous cell cancer: A population-based study

Otolaryngology - Head and Neck Surgery

Volumn 125, Issue 1, 2001, Pages 1-9

  Schwartz, Seth R ^a   Yueh, Bevan ^b   McDougall, James K ^b   Daling, Janet R ^b   Schwartz, Stephen M ^b  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

AGE DISTRIBUTION; ARTICLE; COMORBIDITY; HEALTH SURVEY; INCIDENCE; ISOLATION AND PURIFICATION; MOUTH TUMOR; PAPILLOMA VIRUS; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SEX RATIO; SQUAMOUS CELL CARCINOMA; SURVIVAL; VIRUS INFECTION;

AGE DISTRIBUTION; CARCINOMA, SQUAMOUS CELL; COMORBIDITY; DNA, VIRAL; INCIDENCE; MOUTH NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POPULATION SURVEILLANCE; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TUMOR VIRUS INFECTIONS;

EID: 0035408307     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhn.2001.116979     Document Type: Article

References (20)

1. Smith E. Epidemiology of oral and pharyngeal cancers in the United States: review of recent literature. J Natl Cancer Inst 1979;63:1189-98.
2. Deter J, Goldstein JC. Risk factors in head and neck cancer. N Engl J Med 1982;306:1151-5.
3. Brandsma JL, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 1989;115:621-5.
4. Pas IB, Cook N, Odom-Maryon T, et al. Human papillomavirus (HPV) in head and neck cancer: an association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997;79:595-604.
5. Smith EM, Hoffman HT, Summersgill KS, et al. Human papillomavirus and risk of oral cancer. Laryngoscope 1998;107:1098-103.
6. Gillison ML, Koch WM, Cappone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-20.
7. McKaig RG, Barie RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 1998;20:250-65.
8. Maden C, Beckmann AM, Thomas DB. Human papillomavirus, herpes simplex virus, and the risk of oral cancer in men. Am J Epidemiol 1992;135:1093-102.
9. Schwartz SM, Daling JR, Doody DR, et al. Oral cancer risk in relation to sexual history and evidence of human papilloma virus. J Natl Cancer Inst 1998;90:1626-36.
10. Lombard I, Vincent-Salomon A, Validire P, et al. Human papillomavirus genotype as a major determinant of the course of cervical cancer. J Clin Oncol 1998;16:2613-9.
11. Haraf DJ, Nodzenski E, Brachman D, et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 1996;2:755-62.
12. Chiba I, Shindoh M, Yasuda M, et al. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity. Oncogene 1996;12:1663-8.
13. Rietdorf S, Friedrich RE, Ostwald CH, et al. P53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study. J Oral Pathol Med 1997;25:315-21.
14. Pintos J, Franco EL, Black MJ, et al. HPV detection using "hot start" polymerase chain reaction in patients with oral cancer: a clinicopathological study of 64 patients. Mod Pathol 1994;7:720-7.
15. Brandwein M, Zeitlin J, Nuovo GJ, et al. HPV detection using "hot start" polymerase chain reaction in patients with oral cancer: a clinicopathological study of 64 patients. Mod Pathol 1994;7:720-7.
16. Clayman GL, Stewart MG, Weber RS, et al. Human papillomavirus in laryngeal and hypopharyngeal carcinomas: relationship to survival Arch Otolaryngol Head Neck Surg 1994;120:743-8.
17. Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Pres 1999;8:1117-21.
18. Cox D. Regression models and life tables. JR Stat Soc (B) 1972;34:187-220.
19. DeWeese TL, Walsh JC, Dillehay LE, et al. Human papillomavirus E6 and E7 oncoproteins alter cell cycle progression but not radiosensitivity of carcinoma cells treated with low-dose-rate ionizing radiation. Int J Radiat Oncol Bio Phys 1997;37:145-34.
20. Huang H, Li CY, Little JB. Abrogation of p53 function by transfection of HPV 16 E6 gene does not enhance resistance of human tumor cells to ionizing radiation. Int J Radiat Biol 1996;70:151-60.